Davis J - Search Results

1

Combined immunodeficiency associated with DOCK8 mutations.

Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ, Matthews HF, Davis J, Turner ML, Uzel G, Holland SM, Su HC. Zhang Q, et al. Among authors: davis j, davis jc. N Engl J Med. 2009 Nov 19;361(21):2046-55. doi: 10.1056/NEJMoa0905506. Epub 2009 Sep 23. N Engl J Med. 2009. PMID: 19776401 Free PMC article.

2

Genetic, clinical, and laboratory markers for DOCK8 immunodeficiency syndrome.

Zhang Q, Davis JC, Dove CG, Su HC. Zhang Q, et al. Dis Markers. 2010;29(3-4):131-9. doi: 10.3233/DMA-2010-0737. Dis Markers. 2010. PMID: 21178272 Free PMC article. Review.

3

Second messenger role for Mg2+ revealed by human T-cell immunodeficiency.

Li FY, Chaigne-Delalande B, Kanellopoulou C, Davis JC, Matthews HF, Douek DC, Cohen JI, Uzel G, Su HC, Lenardo MJ. Li FY, et al. Among authors: davis jc. Nature. 2011 Jul 27;475(7357):471-6. doi: 10.1038/nature10246. Nature. 2011. PMID: 21796205 Free PMC article.

4

A pilot study of 2-chloro-2'-deoxyadenosine in the treatment of systemic lupus erythematosus-associated glomerulonephritis.

Davis JC Jr, Austin H 3rd, Boumpas D, Fleisher TA, Yarboro C, Larson A, Balow J, Klippel JH, Scott D. Davis JC Jr, et al. Arthritis Rheum. 1998 Feb;41(2):335-43. doi: 10.1002/1529-0131(199802)41:2<335::AID-ART18>3.0.CO;2-O. Arthritis Rheum. 1998. PMID: 9485092 Review.

5

Lymphocyte depletion with fludarabine in patients with psoriatic arthritis: clinical and immunological effects.

Takada K, Danning CL, Kuroiwa T, Schlimgen R, Tassiulas IO, Davis JC Jr, Yarboro CH, Fleisher TA, Boumpas DT, Illei GG. Takada K, et al. Among authors: davis jc jr. Ann Rheum Dis. 2003 Nov;62(11):1112-5. doi: 10.1136/ard.62.11.1112. Ann Rheum Dis. 2003. PMID: 14583577 Free PMC article. Clinical Trial.

6

High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis.

Davis JC Jr, Fessler BJ, Tassiulas IO, McInnes IB, Yarboro CH, Pillemer S, Wilder R, Fleisher TA, Klippel JH, Boumpas DT. Davis JC Jr, et al. J Rheumatol. 1998 Sep;25(9):1694-704. J Rheumatol. 1998. PMID: 9733448 Clinical Trial.

7

Angiotensin I converting enzyme gene polymorphisms in systemic lupus erythematosus: decreased prevalence of DD genotype in African American patients.

Tassiulas IO, Aksentijevich I, Salmon JE, Kim Y, Yarboro CH, Vaughan EM, Davis JC, Scott DL, Austin HA, Klippel JH, Balow JE, Gourley MF, Boumpas DT. Tassiulas IO, et al. Among authors: davis jc. Clin Nephrol. 1998 Jul;50(1):8-13. Clin Nephrol. 1998. PMID: 9710341

8

Lupus nephritis.

Davis JC, Tassiulas IO, Boumpas DT. Davis JC, et al. Curr Opin Rheumatol. 1996 Sep;8(5):415-23. doi: 10.1097/00002281-199609000-00005. Curr Opin Rheumatol. 1996. PMID: 8941444 Review.

9

Commentary.

Davis JC Jr. Davis JC Jr. J Clin Rheumatol. 1997 Feb;3(1):50. doi: 10.1097/00124743-199702000-00011. J Clin Rheumatol. 1997. PMID: 19078119 No abstract available.

10

Inclusion body myositis long after dermatomyositis: a report of two cases.

McCoy AL, Bubb MR, Plotz PH, Davis JC. McCoy AL, et al. Among authors: davis jc. Clin Exp Rheumatol. 1999 Mar-Apr;17(2):235-9. Clin Exp Rheumatol. 1999. PMID: 10342053

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,865 results

Search Page

Filters